Skip to content

Clinical trials

Mood Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20083
20113
20122
20142
20151
20181
20211
20231
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting5
Enrolling by invitation2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Eli Lilly and Company2
Forschungsinstitut der Diabetes Akademie Mergentheim2
Seaport Therapeutics2
Takeda2
Charite University, Berlin, Germany1
Health and Medical University Potsdam1
HolsboerMaschmeyer NeuroChemie GmbH1
Novartis Pharmaceuticals1
Parnassia Groep1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders21
Major Depressive Disorder14
Depressive Disorder12
Mental Disorders8
Anxiety Disorders4
Substance-Related Disorders3
Diabetes Mellitus2
Personality Disorders2
Diabetes Complications1
Dysthymic Disorder1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.